Syndromic variability of Wilson's disease in children. Clinical study of 44 cases

R Giacchino1, M G Marazzi, A Barabino

  • 1Infectious Disease Department, University of Genoa, Italy.

Italian Journal of Gastroenterology and Hepatology
|April 1, 1997
PubMed

Insights

Diagnosing Wilson's disease in children requires careful evaluation of copper metabolism, as symptoms vary widely. Early detection and treatment are crucial for preventing disease progression in pediatric patients.

Area of Science:

  • Pediatric Hepatology
  • Genetic Metabolic Disorders
  • Clinical Diagnostics

Background:

  • Wilson's disease diagnosis in children lacks specific indicators seen in adults.
  • Clinical presentation and copper metabolism parameters are crucial for pediatric diagnosis.

Purpose of the Study:

  • To establish diagnostic criteria for Wilson's disease in children.
  • To evaluate clinical aspects and copper metabolism in pediatric cases.
  • To guide appropriate treatment strategies, even in complex cases.

Main Methods:

  • Studied 44 children with Wilson's disease, analyzing clinical, histological, and laboratory data.
  • Monitored 40 patients treated with penicillamine for a median of 77 months.
  • Assessed copper metabolism, including ceruloplasmin levels, urine copper excretion, and hepatic copper content.

Main Results:

  • Observed diverse clinical presentations: asymptomatic, chronic hepatitis, hepatocerebral, cirrhosis, and fulminant hepatic failure.
  • Abnormal ceruloplasmin levels in 86% of cases; urine copper was pathological in 83% of tested patients.
  • Hepatic copper levels were significantly elevated in all tested patients; 63% of treated children showed favorable outcomes.

Conclusions:

  • Wilson's disease in children presents with varied liver involvement, necessitating early diagnosis.
  • Clinical suspicion combined with copper metabolism studies, including hepatic copper, is key for diagnosis.
  • Prompt and appropriate treatment can prevent disease progression in pediatric Wilson's disease.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...